<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPL) are known to be pathogenic in experimental models and are predictive of <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> in patients, so it is important to correctly evaluate their presence for identifying patients at risk </plain></SENT>
<SENT sid="1" pm="."><plain>Despite many years of work, the standardization of aPL ELISA remains an open problem, so evaluation of newly introduced commercial preparations is mandatory </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 80 sera were collected (10 primary <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndromes</z:e> (APSs), 10 APSs associated with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, 20 infectious diseases, 20 <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> and 20 <z:mpath ids='MPATH_458'>normal</z:mpath> blood donors) and tested for IgG/IgM anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> and anti-beta2GPI antibodies on commercial ELISA kits (ETI) by DiaSorin and on home-made ELISA </plain></SENT>
<SENT sid="3" pm="."><plain>Both methods displayed good sensitivity and specificity for APS and were found to be concordant, especially in determining antibodies of IgG class </plain></SENT>
</text></document>